Anaptysbio (ANAB) Return on Sales (2016 - 2026)

Anaptysbio's Return on Sales history runs 11 years deep, the most recent figure standing at 0.02% for Q1 2026.

• Quarterly Return on Sales fell 1.0% year-over-year to 0.02% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (up 1.0% YoY) and the FY2025 annual result came in at 0.0%, up 1.0% from the prior year.
• Return on Sales was 0.02% for Q1 2026 at Anaptysbio, down from 0.01% in the prior quarter.
• Across five years, Return on Sales topped out at 0.01% in Q4 2025 and bottomed at 0.58% in Q1 2022.
• A 5-year average of 0.13% and a median of 0.05% in 2022 frame the typical range for Return on Sales.
• Annual changes were most pronounced in 2022 — Return on Sales tumbled 55 bps — and 2024, when it soared 39 bps.
• Anaptysbio's Return on Sales stood at 0.05% in 2022, then slipped by 3 bps to 0.05% in 2023, then surged by 107 bps to 0.0% in 2024, then soared by 92 bps to 0.01% in 2025, then sank by 409 bps to 0.02% in 2026.
• Business Quant data shows ANAB's Return on Sales at 0.02% in Q1 2026, 0.01% in Q4 2025, and 0.0% in Q3 2025.